Phase 2 study of the focal adhesion kinase inhibitor defactinib (VS-6063) in previously treated advanced KRAS mutant non-small cell lung cancer - Concepedia

Concepedia

Publication | Open Access

Phase 2 study of the focal adhesion kinase inhibitor defactinib (VS-6063) in previously treated advanced KRAS mutant non-small cell lung cancer

DOI Full Paper Access

173

Citations

32

References

2019

Year

David E. Gerber, D. Ross Camidge, Daniel Morgensztern, Jeremey Cetnar, Ronan J. Kelly, Suresh S. Ramalingam, David R. Spigel, Woondong Jeong, Pier Paolo Scaglioni, Song Zhang,

Tumor BiologyMedicineCancer BiologyCancer TreatmentPhase 2Radiation OncologyOncologyCell BiologyLung CancerCancer Research

References

	Year	Citations

Page 1

Page 1